A Study to Evaluate the Safety and Efficacy of VIB4920 in Participants With Rheumatoid Arthritis
Public ClinicalTrials.gov record NCT04163991. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Mechanistic Insight and Dosage Optimization Study of the Efficacy and Safety of VIB4920 in Patients With Rheumatoid Arthritis (RA)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of the study is to evaluate the efficacy, safety, and pharmacokinetics (PK) of VIB4920 (formerly MEDI4920) in adult participants with rheumatoid arthritis (RA).
Study identification
- NCT ID
- NCT04163991
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 78 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 99 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 8, 2019
- Primary completion
- Dec 27, 2021
- Completion
- Dec 27, 2021
- Last update posted
- Dec 16, 2024
2019 – 2021
United States locations
- U.S. sites
- 18
- U.S. states
- 12
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Anniston | Alabama | 36207 | — |
| Research Site | Sun City | Arizona | 85704 | — |
| Research Site | Upland | California | 91786 | — |
| Research Site | Clearwater | Florida | 33765 | — |
| Research Site | Margate | Florida | 33063 | — |
| Research Site | Miami Lakes | Florida | 33014 | — |
| Research Site | Zephyrhills | Florida | 33542 | — |
| Research Site | Atlanta | Georgia | 30342 | — |
| Research Site | Lexington | Kentucky | 40504 | — |
| Research Site | Wheaton | Maryland | 20902 | — |
| Research Site | Charlotte | North Carolina | 28210 | — |
| Research Site | Rocky Mount | North Carolina | 27804 | — |
| Research Site | Salisbury | North Carolina | 28144 | — |
| Research Site | Vandalia | Ohio | 45377 | — |
| Research Site | Norman | Oklahoma | 73069 | — |
| Research Site | Duncansville | Pennsylvania | 16635 | — |
| Research Site | Baytown | Texas | 77477 | — |
| Research Site | Dallas | Texas | 75231 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04163991, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 16, 2024 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04163991 live on ClinicalTrials.gov.